Refine by
In Vivo Tests Services Available In Iran
6 services found
by:Biomcare ApS based inAarhus, DENMARK
It is often valuable to study the effect of a product on the gut microbiome or the influence of the microbiome on the effect of a new product, in a controlled setting that eliminates many of the confounding factors that affect the microbiome. Therefore, we offer in vivo tests of new products such as drugs and food ingredients including pre-tox studies, in an ...
Manufactured by:InnoSer Belgie NV based inDiepenbeek, BELGIUM
We move your identified hits forward into in vivo testing and lead optimization. As a critical phase in your drug development journey, the hit to lead phase will determine which of your promising compounds will be characterized against your targets. With a lean ethos, InnoSer is dedicated to combining our expertise with your drug development goals in the most ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Custom In Vivo Models and Testing Solutions. Selecting the appropriate in vivo model for your assays is critical for the success of your preclinical research program. At Nexelis, a Q² Solutions Company, we designed and developed disease specific in vivo models alongside bespoke personalized model development services. ...
Manufactured by:Avania based inBrunswick, AUSTRALIA
We will partner with you to define, develop, document, and deliver a preclinical strategy, encompassing all aspects of product validation and verification, to bring your product to ...
by:Base Pair Biotechnologies, Inc. based inPearland, TEXAS (USA)
Aptamer discovery is a complex process. Customized libraries and selection techniques are employed to achieve selective binding to a target of interest under anticipated conditions. In some cases, selected aptamers may not quite achieve the degree of affinity or stability required for a specific end-use application. In addition, aptamer modification for immobilization or signal generation is ...
Manufactured by:Newcells Biotech Limited based inNewcastle Upon Tyne, UNITED KINGDOM
Cross-species comparison of drug handling with near-physiological kidney transporter model. New drug molecules are usually tested in vivo in two preclinical species to gain a more detailed understanding of how they are transported and eliminated through the kidney and also to mitigate risk of renal toxicity in humans. However, these animal models are not always ...